Nova Leap Health Corp
(NLH.VN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 218 | 206 | 223 | 215 | 163 |
| Income taxes - deferred | 1,827 | -118 | -1,682 | -1,249 | -1,040 |
| Accounts receivable | -336 | -341 | 149 | -235 | -60 |
| Accounts payable and accrued liabilities | -156 | 106 | 282 | 132 | -179 |
| Other Working Capital | -1,081 | 273 | 368 | -157 | -125 |
| Other Operating Activity | 105 | 1,464 | 766 | 1,201 | 1,096 |
| Operating Cash Flow | $577 | $1,591 | $105 | $-93 | $-145 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -1 |
| Net Acquisitions | -6,177 | -1,225 | N/A | N/A | -1,413 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 56 |
| Investing Cash Flow | $-6,177 | $-1,225 | $N/A | $N/A | $-1,357 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 101 |
| Debt Repayment | -506 | -290 | -358 | -292 | -402 |
| Common Stock Issued | 0 | N/A | 4,454 | N/A | N/A |
| Common Stock Repurchased | N/A | -74 | N/A | N/A | N/A |
| Other Financing Activity | 1,522 | -21 | -41 | -64 | -168 |
| Financing Cash Flow | $1,016 | $-385 | $4,055 | $-356 | $-469 |
| Exchange Rate Effect | -3 | -116 | -56 | 22 | 64 |
| Beginning Cash Position | 6,320 | 6,455 | 2,351 | 2,779 | 4,686 |
| End Cash Position | 1,733 | 6,320 | 6,455 | 2,351 | 2,779 |
| Net Cash Flow | $-4,583 | $-19 | $4,160 | $-449 | $-1,971 |
| Free Cash Flow | |||||
| Operating Cash Flow | 577 | 1,591 | 105 | -93 | -145 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -1 |
| Free Cash Flow | 577 | 1,591 | 105 | -93 | -146 |